EWTX SCHEDULE 13G/A: SEC filing

An institutional investor

Filed with the SEC on · accession 0000315066-26-002741

EWTX filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 5, 2026. An institutional investor filed an amended Schedule 13G regarding its beneficial ownership position in Edgewise Therapeutics, Inc. (EWTX). The stock moved +3.6% by the first close after the filing.

Summary of the filing

An institutional investor filed an amended Schedule 13G regarding its beneficial ownership position in Edgewise Therapeutics, Inc. (EWTX). The filing indicates a change in the holder's ownership stake.

Key details

IssuerEdgewise Therapeutics, Inc.

How EWTX stock reacted

Close before

$37.53

Nov 4, 2026

First close after

+3.57%

$38.87

5 trading days

—

Since filing

+20.01%

$45.04

✦ Ask GOAX AI about this filing — what it means for EWTX, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for EWTX?

Click here

Frequently asked questions

What did EWTX file with the SEC on Nov 5, 2026?

EWTX filed a SCHEDULE 13G/A (SEC filing). An institutional investor filed an amended Schedule 13G regarding its beneficial ownership position in Edgewise Therapeutics, Inc. (EWTX). The filing indicates a change in the holder's ownership stake.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did EWTX stock react to this filing?

EWTX closed at $37.53 before the filing and $38.87 on Nov 5, 2026 (+3.57%).

Other EWTX SEC filings

Get alerts when EWTX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days